Model-based economic evaluations of interventions for dementia: An updated systematic review and quality assessment

MG Darab, L Engel, D Henzler, M Lauerer… - … Health Economics and …, 2024 - Springer
Background There has been an increase in model-based economic evaluations of
interventions for dementia. The most recent systematic review of economic evaluations for …

Economics and dementia: Challenges and responses

M Knapp, G Wong - Dementia, 2024 - journals.sagepub.com
Economics and dementia are interconnected in many ways. There is, for example,
accumulating evidence of the ways in which dementia impacts on the economic status of …

Cost Effectiveness Analysis of Alzheimer's Disease.

S EROYMAK, V YİĞİT - Turkiye Klinikleri Journal of Health …, 2020 - search.ebscohost.com
Objective: Chronic diseases, comparing to the other type of diseases, consume most of the
resources in the health systems. Alzheimer's Disease (AD) is a chronic cerebral disorder …

Doença de alzheimer: os desafios do cuidado

JVGS Ferreira, AP Esteves - … de Medicina de Família e Saúde …, 2020 - revista.unifeso.edu.br
Introdução: A Doença de Alzheimer (DA) é uma patologia neurodegenerativa progressiva
mais comum relacionada à idade que se manifesta por deterioração cognitiva e da …

[HTML][HTML] Alzheimer's disease: an epidemiological analysis over the number of hospitalizations and deaths in Brazil

EC Piovesan, BZ Freitas, FCB Lemanski… - Arquivos de Neuro …, 2023 - SciELO Brasil
Background Alzheimer's disease (AD) is a neurodegenerative condition characterized by
impaired cognitive function. It results in high morbidity, including a large number of …

Quantitative and qualitative analysis of neuroinflammation by beta amyloid 1-42 toxin after treatment with resveratrol-loaded nanoparticles

MMSV de Lima, MER Cordeiro, FK Kerppers… - Medicina (Ribeirão …, 2023 - revistas.usp.br
Background: This study evaluated the effects of zein nanoparticles with resveratrol on
neuroinflammation caused by Alzheimer's disease. Method: The sample consisted of 30 …

Uso dos biomarcadores plasmáticos na otimização do diagnóstico precoce do Alzheimer

MA de Oliveira, JC Rolim, TBS de Sousa… - Revista Brasileira …, 2021 - revistarebram.com
Objetivo: Avaliar a eficácia do uso de biomarcadores plasmáticos no diagnóstico precoce
do Alzheimer. Metodologia: O presente estudo trata-se de uma revisão integrativa da …

Qualidade metodológica de estudos experimentais com canabinóides na doença de alzheimer uma revisão sistemática

MEK TEIXEIRA - 2023 - repositorio.bahiana.edu.br
INTRODUÇÃO: A doença de Alzheimer é uma condição neurodegenerativa que causa
deterioração cognitiva e perda de memória, afetando a qualidade de vida dos indivíduos …

Pharmacoeconomics

R Dodel, C Kruse, A Conrads-Frank… - …, 2020 - Springer
Newly developed drugs and medical devices have made a major contribution to improving
the health of populations. However, the rise in health care expenditure has been a major …

[PDF][PDF] Health Technology Assessment (HTA)

S Wieser - 2019 - zhaw.ch
Background: Currently, no disease-modifying treatment is available for Alzheimer disease
(AD) or Parkinson's disease dementia (PD). Professional societies in Switzerland generally …